Almudena del Avellan

43.4K posts

Almudena del Avellan banner
Almudena del Avellan

Almudena del Avellan

@ALMUAVE

Psicóloga ;alzheimer,neurodegeneración, master gestión de estrés y dolor crónico, hipnosis clínica.Apasionada de su trabajo,en constante aprendizaje.Fiel amiga.

Madrid Katılım Mart 2011
941 Takip Edilen1.7K Takipçiler
Sabitlenmiş Tweet
Almudena del Avellan
Almudena del Avellan@ALMUAVE·
En una de las ponencias que tuve el gusto de compartir durante el IX Congreso Iberoamericano de Alzheimer @ASCADACR
Almudena del Avellan tweet media
Santa Cruz, Costa Rica 🇨🇷 Español
2
3
25
0
Bella 🇱🇷
Bella 🇱🇷@Bella_91m7u·
Spot the odd one out… not as easy as it looks!Only sharp minds will get it right 💡
Bella 🇱🇷 tweet media
English
14.9K
320
2K
385.8K
Almudena del Avellan retweetledi
S. Navarra Geriatría 👵👴
S. Navarra Geriatría 👵👴@sngeriatria·
🗓️ Taller: "Síndromes disruptivos en demencia" Aprende sobre el Síndrome del Atardecer, Falsas Identificaciones y Síndrome de la Sombra con expertos en geriatría, psiquiatría y psicología.
S. Navarra Geriatría 👵👴 tweet media
Español
1
1
4
72
Almudena del Avellan retweetledi
Eric Topol
Eric Topol@EricTopol·
The effect of current anti-amyloid drugs vs Alzheimer's disease is "trivial" for cognitive function or dementia severity, not clinically meaningful, from a systematic @cochranecollab review of 17 trials, >20,000 patients cochranelibrary.com/cdsr/doi/10.10…
Eric Topol tweet media
English
17
100
301
102.7K
El Toro TV
El Toro TV@eltorotv·
"Tuve que trabajar 12 HORAS DIARIAS para mantenerle" 💼 Perdió a su padre, enfermo de ELA, solo DOS MESES antes de que llegasen las primeras ayudas ⏰
Español
5
17
51
5.8K
Almudena del Avellan
Almudena del Avellan@ALMUAVE·
@eltorotv Totalmente cierto, les conozco bien. Hijas entregadas y arrimando el hombro en casa para que su padre tuviera los mejores cuidados y apoyar a su madre en ese camino sin retorno de esta terrible enfermedad.
Español
0
0
0
0
Almudena del Avellan
Almudena del Avellan@ALMUAVE·
Cognito Therapeutics announced the close of an oversubscribed $105 million Series C, bringing its total funding to $233 million.
Doug Drysdale@insidepharma

$105 million for the next frontier of Alzheimer’s treatment - and it’s not another monoclonal antibody. Cognito Therapeutics announced the close of an oversubscribed $105 million Series C, bringing its total funding to $233 million. The round was led by Morningside Ventures, IAG Capital Partners, and Starbloom Capital, with strong participation from new investors including New Vintage Partners, Apollo Health Ventures, and Benvolio Group. At the center of this momentum is Spectris, a physician-prescribed, at-home wearable neurostimulation device that looks like sleek sunglasses connected to over-ear headphones. Patients simply wear it for one hour per day while it delivers precisely synchronized 40 Hz gamma-frequency light and sound stimulation. By non-invasively restoring disrupted gamma brain rhythms that decline early in Alzheimer’s, the therapy drives meaningful downstream effects. It reduces amyloid and tau pathology, helps preserve brain structure such as the corpus callosum, and meaningfully slows neurodegeneration. In the completed OVERTURE Phase 2 randomized, sham-controlled study and its open-label extension, patients using Spectris experienced a 77 percent reduction in the decline of daily function on the ADCS-ADL scale, a 76 percent reduction in cognitive decline on the MMSE, a 69 percent reduction on the integrated Alzheimer’s Disease Rating Scale, and a 56 percent lower Alzheimer’s Dependence Score. These benefits were sustained through the 18-month open-label extension, all with excellent safety and no serious device-related adverse events. The device carries FDA Breakthrough Device Designation for cognitive and functional symptoms in Alzheimer’s. A non-pharmacological, disease-modifying therapy that patients can use comfortably at home, with the potential for fewer side effects and far broader accessibility than today’s anti-amyloid infusions. It also opens the door for future expansion into other neurodegenerative diseases. #AlzheimersDisease #Neurotechnology #Neurodegeneration #DigitalHealth #Biopharma #Neuroscience #BreakthroughDevice #Longevity

English
0
1
2
75
Nina Varsavsky
Nina Varsavsky@ninavars·
El problema no es la inmigración. En Düsseldorf vive una de las comunidades japonesas más grandes fuera de Japón, con más de 8.000 residentes. Y nadie se queja de ellos. ¿Por qué? Porque respetan, trabajan, no imponen su cultura ni generan conflictos. El verdadero problema es la inmigración masiva desde el Tercer Mundo, donde muchos llegan sin intención de integrarse y con valores incompatibles con los nuestros. No se trata de racismo. Se trata de realidad. Y de sentido común.
Nina Varsavsky tweet media
Español
932
8.6K
28.4K
772.3K

Keşfet

@Bella_91m7u @cochranecollab @eltorotv @kitty_894 @ninavars @lavanya73_ir @EmergenciasMad @112cmadrid